2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …

TA McDonagh, M Metra, M Adamo… - European heart …, 2021 - academic.oup.com
The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …

Management of hyperkalemia in the acutely ill patient

F Dépret, WF Peacock, KD Liu, Z Rafique… - Annals of Intensive …, 2019 - Springer
Purpose To review the mechanisms of action, expected efficacy and side effects of strategies
to control hyperkalemia in acutely ill patients. Methods We searched MEDLINE and …

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …

Authors/Task Force Members:… - European journal of …, 2022 - Wiley Online Library
Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …

Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and/or diabetes

AJ Collins, B Pitt, N Reaven, S Funk… - American journal of …, 2017 - karger.com
Background: The relationship between serum potassium, mortality, and conditions
commonly associated with dyskalemias, such as heart failure (HF), chronic kidney disease …

Eplerenone in patients with systolic heart failure and mild symptoms

F Zannad, JJV McMurray, H Krum… - … England Journal of …, 2011 - Mass Medical Soc
Background Mineralocorticoid antagonists improve survival among patients with chronic,
severe systolic heart failure and heart failure after myocardial infarction. We evaluated the …

Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents: the PARTAGE study

A Benetos, C Labat, P Rossignol, R Fay… - JAMA internal …, 2015 - jamanetwork.com
Importance Clinical evidence supports the beneficial effects of lowering blood pressure (BP)
levels in community-living, robust, hypertensive individuals older than 80 years. However …

Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an …

YS Chen, JW Lin, HY Yu, WJ Ko, JS Jerng, WT Chang… - The Lancet, 2008 - thelancet.com
Background Extracorporeal life-support as an adjunct to cardiac resuscitation has shown
encouraging outcomes in patients with cardiac arrest. However, there is little evidence about …

Electrolyte disorders in community subjects: prevalence and risk factors

G Liamis, EM Rodenburg, A Hofman, R Zietse… - The American journal of …, 2013 - Elsevier
BACKGROUND: Electrolyte disorders have been studied mainly in hospitalized patients,
whereas data in the general population are limited. The aim of this study was to determine …

Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the …

B Pitt, SD Anker, DA Bushinsky… - European heart …, 2011 - academic.oup.com
Aims To evaluate efficacy and safety of RLY5016 (a non-absorbed, orally administered,
potassium [K+]-binding polymer) on serum K+ levels in patients with chronic heart failure …

Associations of serum potassium levels with mortality in chronic heart failure patients

M Aldahl, ASC Jensen, L Davidsen… - European Heart …, 2017 - academic.oup.com
Aims Medication prescribed to patients suffering from chronic heart failure carries an
increased risk of impaired potassium homeostasis. We examined the relation between …